Showing results 42 to 61 of 80
< previous
next >
Issue Date | Title | Author(s) |
2019-03-04 | High expression of IDO1 and TGF-?1 during recurrence and post infection clearance with Chlamydia trachomatis, are independent of host IFN-? response | Ziklo, N; Huston, WM; Taing, K; Timms, P |
2015-07-01 | Human and pathogen factors associated with chlamydia trachomatis-related infertility in women | Menon, S; Timms, P; Allan, JA; Alexander, K; Rombauts, L; Horner, P; Keltz, M; Hocking, J; Huston, WM |
2015-02-17 | Human Chlamydia pneumoniae isolates demonstrate ability to recover infectivity following penicillin treatment whereas animal isolates do not | Chacko, A; Beagley, KW; Timms, P; Huston, WM |
2013-08-01 | Identification of a serine protease inhibitor which causes inclusion vacuole reduction and is lethal to Chlamydia trachomatis | Gloeckl, S; Ong, VA; Patel, P; Tyndall, JDA; Timms, P; Beagley, KW; Allan, JA; Armitage, CW; Turnbull, L; Whitchurch, CB; Merdanovic, M; Ehrmann, M; Powers, JC; Oleksyszyn, J; Verdoes, M; Bogyo, M; Huston, WM |
2023-01-01 | IgG exacerbates genital chlamydial pathology in females by enhancing pathogenic CD8<sup>+</sup> T cell responses | Armitage, CW; O'Meara, CP; Bryan, ER; Kollipara, A; Trim, LK; Hickey, D; Carey, AJ; Huston, WM; Donnelly, G; Yazdani, A; Blumberg, RS; Beagley, KW |
2013-11-15 | The IL-6 response to Chlamydia from primary reproductive epithelial cells is highly variable and may be involved in differential susceptibility to the immunopathological consequences of chlamydial infection | Cunningham, K; Stansfield, SH; Patel, P; Menon, S; Kienzle, V; Allan, JA; Huston, WM |
- | Immunoassay to categorize chlamydial inflammatory disease in women to develop biomarker from peptide derived stimulant and its response to cytokine | Vats, A; Menon, S; Huston, WM; Timms, P; Mittal, A |
2016-12-03 | In vitro rescue of genital strains of Chlamydia trachomatis from interferon-γ and tryptophan depletion with indole-positive, but not indole-negative Prevotella spp. | Ziklo, N; Huston, WM; Taing, K; Katouli, M; Timms, P |
2015-11-01 | In vitro susceptibility of recent Chlamydia trachomatis clinical isolates to the CtHtrA inhibitor JO146 | Ong, VA; Lawrence, A; Timms, P; Vodstrcil, LA; Tabrizi, SN; Beagley, KW; Allan, JA; Hocking, JS; Huston, WM |
2014-01-01 | Increased sensitivity to tryptophan bioavailability is a positive adaptation by the human strains of Chlamydia pneumoniae | Chacko, A; Barker, CJ; Beagley, KW; Hodson, MP; Plan, MR; Timms, P; Huston, WM |
2022 | Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study. | Bittleston, H; Hocking, JS; Goller, JL; Coombe, J; Bateson, D; Sweeney, S; Fleming, K; Huston, WM; Fuller, SS |
2021-01 | Koala cathelicidin PhciCath5 has antimicrobial activity, including against Chlamydia pecorum. | Peel, E; Cheng, Y; Djordjevic, JT; O'Meally, D; Thomas, M; Kuhn, M; Sorrell, TC; Huston, WM; Belov, K |
2018-10-01 | A laboratory competency examination in microbiology | Wang, JTH; Huston, WM; Johanesen, P; Lloyd, M; Waller, KL |
2017-03-10 | Laser-mediated rupture of chlamydial inclusions triggers pathogen egress and host cell necrosis | Kerr, MC; Gomez, GA; Ferguson, C; Tanzer, MC; Murphy, JM; Yap, AS; Parton, RG; Huston, WM; Teasdale, RD |
2019-01-02 | Life inside and out: making and breaking protein disulfide bonds in Chlamydia | Christensen, S; McMahon, RM; Martin, JL; Huston, WM |
2017-05-01 | Measurement of tissue azithromycin levels in self-collected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry (LC-MS/MS) | Vodstrcil, LA; Rupasinghe, TWT; Kong, FYS; Tull, D; Worthington, K; Chen, MY; Huston, WM; Timms, P; McConville, MJ; Fairley, CK; Bradshaw, CS; Tabrizi, SN; Hocking, JS |
2017-12-01 | Molecular evidence of Chlamydia pecorum and arthropod-associated Chlamydiae in an expanded range of marsupials | Burnard, D; Huston, WM; Webb, JK; Jelocnik, M; Reiss, A; Gillett, A; Fitzgibbon, S; Carver, S; Carrucan, J; Flanagan, C; Timms, P; Polkinghorne, A |
- | Molecular pathogenesis of Chlamydia trachomatis | Jury, B; Fleming, C; Huston, WM; Luu, LDW |
2021-11 | Optimization of peptide-based inhibitors targeting the HtrA serine protease in Chlamydia: Design, synthesis and biological evaluation of pyridone-based and N-Capping group-modified analogues. | Hwang, J; Strange, N; Phillips, MJA; Krause, AL; Heywood, A; Gamble, AB; Huston, WM; Tyndall, JDA |
2019-01-01 | Oxidoreductase disulfide bond proteins DsbA and DsbB form an active redox pair in Chlamydia trachomatis, a bacterium with disulfide dependent infection and development | Christensen, S; Halili, MA; Strange, N; Petit, GA; Huston, WM; Martin, JL; McMahon, RM |